- Home
- BLCO vs BPMC Comparison
BLCO vs BPMC Comparison
Compare BLCO & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- BPMC
- Stock Information
- Founded
- BLCO 1853
- BPMC 2008
- Country
- BLCO Canada
- BPMC United States
- Employees
- BLCO N/A
- BPMC N/A
- Industry
- BLCO Ophthalmic Goods
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- BLCO Health Care
- BPMC Health Care
- Exchange
- BLCO Nasdaq
- BPMC Nasdaq
- Market Cap
- BLCO 4.3B
- BPMC 5.8B
- IPO Year
- BLCO 2022
- BPMC 2015
- Fundamental
- Price
- BLCO $13.88
- BPMC $128.35
- Analyst Decision
- BLCO Hold
- BPMC Buy
- Analyst Count
- BLCO 13
- BPMC 20
- Target Price
- BLCO $15.63
- BPMC $127.82
- AVG Volume (30 Days)
- BLCO 784.0K
- BPMC 3.6M
- Earning Date
- BLCO 07-30-2025
- BPMC 07-31-2025
- Dividend Yield
- BLCO N/A
- BPMC N/A
- EPS Growth
- BLCO N/A
- BPMC N/A
- EPS
- BLCO N/A
- BPMC N/A
- Revenue
- BLCO $4,829,000,000.00
- BPMC $562,121,000.00
- Revenue This Year
- BLCO $6.97
- BPMC $44.46
- Revenue Next Year
- BLCO $5.48
- BPMC $32.78
- P/E Ratio
- BLCO N/A
- BPMC N/A
- Revenue Growth
- BLCO 11.94
- BPMC 99.19
- 52 Week Low
- BLCO $10.45
- BPMC $73.04
- 52 Week High
- BLCO $21.69
- BPMC $128.52
- Technical
- Relative Strength Index (RSI)
- BLCO 73.20
- BPMC 74.59
- Support Level
- BLCO $12.02
- BPMC $128.06
- Resistance Level
- BLCO $12.31
- BPMC $128.52
- Average True Range (ATR)
- BLCO 0.46
- BPMC 0.28
- MACD
- BLCO 0.22
- BPMC -1.18
- Stochastic Oscillator
- BLCO 97.60
- BPMC 74.44
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.